Silva Markovic‐Plese

Author

University of North Carolina at Chapel Hill ORCID

Also Known As

Armao, Diane, Bennett-Irving Machanic, Collinge, Mark, Dwyer, Michael G., Gibson S.A, Li, Jian-Liang, Markovic-Plese, Silva, Marković-Pleše, Silva, Meeker, Rick B., S Markovic-Plese

116

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill National Institute of Neurological Disorders and Stroke National Institutes of Health National Cancer Institute Yale University

About

Silva Markovic‐Plese is an author at University of North Carolina at Chapel Hill specializing in medicine, immunology, and multiple sclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	27	3.2K
2	Allergy	3	3	107
3	Engineering	1	1	169
4	Health Sciences	1	1	36
5	Social Sciences	1	1	28

Silva Markovic‐Plese

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Zhang, Silva Markovic‐Plese, B Lacet, The Journal of Experimental Medicine Clinical ImmunologyMyelin-reactive T CellsT-regulatory CellImmunologyImmune Regulation	1994	532
Oral simvastatin treatment in relapsing-remitting multiple sclerosis Timothy R. Vollmer, Lyndon Key, Valerie Durkalski, The Lancet Oral Simvastatin TreatmentNeurological DisorderPharmacotherapyNeurologyMultiple Sclerosis	2004	469
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β Bibiana Bielekova, Nancy Richert, T. Howard, Proceedings of the National Academy of Sciences Neurological DisorderImmunologyImmune SystemImmunotherapyImmune Dysregulation	2004	313
IFN-β Inhibits Human Th17 Cell Differentiation Vinod S. Ramgolam, Yonggang Sha, Jianping Jin, The Journal of Immunology T-regulatory CellImmunologyImmune RegulationImmunologic MechanismCd4 T Cell Responses	2009	222
CD4+CD28– costimulation-independent T cells in multiple sclerosis Silva Markovic‐Plese, Irene Cortese, Klaus‐Peter Wandinger, Journal of Clinical Investigation	2001	217
CD4+CD28– costimulation-independent T cells in multiple sclerosis Silva Markovic‐Plese, Irene Cortese, Klaus‐Peter Wandinger, Journal of Clinical Investigation Cd4+ SubpopulationAdaptive Immune SystemImmune RegulationImmunologyImmunodominance	2001	208
Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes Xin Zhang, Jianping Jin, Xueyan Peng, The Journal of Immunology Immune RegulationImmunologyT CellsImmunotherapyCd4+ Lymphocytes	2008	199
3D Segmentation in the Clinic: A Grand Challenge II: MS lesion segmentation Martin Styner, Joohwi Lee, Brian Chin, EngineeringMs Lesion SegmentationSurgeryBrain LesionDiagnostic Imaging	2008	169
Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing–Remitting Multiple Sclerosis Xin Zhang, Yazhong Tao, Manisha Chopra, The Journal of Immunology	2013	160
CX3CR1 drives cytotoxic CD4+CD28− T cells into the brain of multiple sclerosis patients Bieke Broux, Kim Pannemans, Xin Zhang, Journal of Autoimmunity Multiple Sclerosis PatientsAutoimmune DiseaseMedicineImmunologyImmune Regulation	2011	134

Page 1